NVCTNuvectis Pharma, Inc.Nov 4, 2026Q3 2026
Read transcript →Nuvectis Pharma, Inc. (NVCT) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$19.76
-5.50%
Mkt Cap $682.59M
NVCTNuvectis Pharma, Inc.Nov 4, 2026NVCTNuvectis Pharma, Inc.Nov 4, 2026